基本信息
浏览量:3
职业迁徙
个人简介
Dr. Borden's research program focuses on a particular protein, the eIF4E, and how its dysregulation leads to transformation and leukemia. A better understanding of the function and subsequent biochemical underpinnings of this protein could prove useful in the development of therapies to treat leukemia. One such therapy is ribavirin, which successfully targeted eIF4E in poor prognosis acute myeloid leukemia (AML) leading to remissions in some patients. Ongoing trials are focused on increasing the durability and frequency of remissions by combining ribavirin with other agents.
研究兴趣
论文共 179 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nucleus (Austin, Tex.)no. 1 (2024): 2360196-2360196
Journal of Molecular Biology/Journal of molecular biologyno. 2 (2024): 168378-168378
crossref(2023)
openalex(2023)
BioEssays : news and reviews in molecular, cellular and developmental biologyno. 1 (2023): e2300145-e2300145
crossref(2023)
加载更多
作者统计
#Papers: 178
#Citation: 11649
H-Index: 62
G-Index: 106
Sociability: 6
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn